{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:19:15Z","timestamp":1792448355237,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5U01HG007674"],"award-info":[{"award-number":["5U01HG007674"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003056","name":"Ente Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022750","name":"Office of the Vice President for Research, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019803","name":"Center for Health Sciences, Oklahoma State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007927","name":"The University of Oklahoma Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111217","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:20:06Z","timestamp":1733790006000},"page":"111217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in na\u00efve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission"],"prefix":"10.1016","volume":"136","author":[{"given":"Hugo R.","family":"Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Luethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Valenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Le\u015bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Czartoryska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Olejarz-Maciej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Doroz-P\u0142onka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Novella","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Handzlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdeslam","family":"Chagraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111217_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108194","article-title":"Coronaridine congeners decrease neuropathic pain in mice and inhibit alpha9alpha10 nicotinic acetylcholine receptors and ca(V)2.2 channels","volume":"175","author":"Arias","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175454","article-title":"(+)-Catharanthine and (\u2212)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission","volume":"939","author":"Arias","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175854","article-title":"Coronaridine congeners induce sedative and anxiolytic-like activity in naive and stressed\/anxious mice by allosteric mechanisms involving increased GABA(a) receptor affinity for GABA","volume":"953","author":"Arias","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116867","article-title":"Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT(2A) receptor activation","volume":"177","author":"Arias","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176329","article-title":"The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT(2A) receptor activation","volume":"966","author":"Arias","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2005.12.001","article-title":"Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats","volume":"169","author":"Brenes Saenz","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0040","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115028","article-title":"\u201cselective\u201d serotonin 5-HT(2A) receptor antagonists","volume":"200","author":"Casey","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopsych.2021.04.024","article-title":"Fluoroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior","volume":"90","author":"Chen","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0060","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.110.172247","article-title":"Interaction of 5-HT2A and 5-HT2C receptors in R(\u2212)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice","volume":"335","author":"Fantegrossi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-008-1167-y","article-title":"Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise","volume":"199","author":"Greenwood","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114329","article-title":"Overcoming undesirable hERG affinity by incorporating fluorine atoms: a case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines","volume":"236","author":"Grychowska","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0075","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1021\/acs.jmedchem.3c01482","article-title":"Superiority of the triple-acting 5-HT(6)R\/5-HT(3)R antagonist and MAO-B reversible inhibitor PZ-1922 over 5-HT(6)R antagonist Intepirdine in alleviation of cognitive deficits in rats","volume":"66","author":"Grychowska","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/psymed.2023.0009","article-title":"Tabernanthalog reduces motivation for heroin and alcohol in a Polydrug use model","volume":"1","author":"Heinsbroek","year":"2023","journal-title":"Psychedelic Med (New Rochelle)"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0090","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00213-022-06092-x","article-title":"Effects of the 5-HT(2A) receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents","volume":"239","author":"Jaster","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0095","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1016\/j.bmc.2013.09.044","article-title":"1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases","volume":"21","author":"Koch","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108717","article-title":"A systematic literature review of clinical trials and therapeutic applications of ibogaine","volume":"138","author":"K\u00f6ck","year":"2022","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0105","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1016\/j.bmcl.2018.10.048","article-title":"4-tert-Pentylphenoxyalkyl derivatives - histamine H(3) receptor ligands and monoamine oxidase B inhibitors","volume":"28","author":"Lazewska","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0110","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105785","article-title":"Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic cortex","volume":"178","author":"Looschen","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0120","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41380-021-01159-1","article-title":"An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress","volume":"26","author":"Lu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2017.07.012","article-title":"Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)","volume":"134","author":"Luethi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0130","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000414","article-title":"Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands","volume":"354","author":"Magli","year":"2021","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.physbeh.2006.08.021","article-title":"Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats","volume":"90","author":"Marin","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0145","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/npp.2015.335","article-title":"Essential contributions of serotonin transporter inhibition to the acute and chronic actions of fluoxetine and citalopram in the SERT Met172 mouse","volume":"41","author":"Nackenoff","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.12688\/f1000research.9736.1","article-title":"Serotonin receptors in depression: from a to B","volume":"6","author":"Nautiyal","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158814","article-title":"The implication of 5-HT receptor family members in aggression, depression and suicide: similarity and difference","volume":"23","author":"Popova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41386-024-01794-6","article-title":"Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT(2A) receptor the unique player?","volume":"49","author":"Sekssaoui","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0170","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1210\/en.2013-2076","article-title":"Molecular basis for the activation of gonadotropin-inhibitory hormone gene transcription by corticosterone","volume":"155","author":"Son","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0175","article-title":"A chronic immobilization stress protocol for inducing depression-like behavior in mice","author":"Son","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0180","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1021\/jm400336x","article-title":"Dual targeting of adenosine a(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones","volume":"56","author":"St\u00f6ssel","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0185","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/acschemneuro.3c00212","article-title":"DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a novel derivative of Ibogamine, inhibits alpha7 and alpha9alpha10 nicotinic acetylcholine receptors by different allosteric mechanisms","volume":"14","author":"Tae","year":"2023","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116183","article-title":"Tabernanthalog and ibogainalog inhibit the alpha7 and alpha9alpha10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA(a) receptor and ca(V)2.2 channel","volume":"223","author":"Tae","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0195","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1038\/s41598-023-34395-2","article-title":"Profiling of adrenal corticosteroids in blood and local tissues of mice during chronic stress","volume":"13","author":"Vagnerova","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111217_bb0200","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.pnpbp.2024.111217_bb0205","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/acschemneuro.3c00478","article-title":"Catharanthine modulates mesolimbic dopamine transmission and nicotine psychomotor effects via inhibition of alpha6-nicotinic receptors and dopamine transporters","volume":"15","author":"Williams","year":"2024","journal-title":"ACS Chem. Nerosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:28:24Z","timestamp":1745854104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S0278584624002859"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111217","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in na\u00efve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111217"}}